(DBXD) Xtrackers - DAX - Ratings and Ratios
Equity, Germany, Large-Cap, ETF, EUR
| Risk via 10d forecast | |
|---|---|
| Volatility | 16.0% |
| Value at Risk 5%th | 26.9% |
| Relative Tail Risk | 1.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.82 |
| Alpha | 13.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.447 |
| Beta | 0.180 |
| Beta Downside | 0.254 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.92% |
| Mean DD | 2.25% |
| Median DD | 1.58% |
Description: DBXD Xtrackers - DAX November 05, 2025
The Xtrackers DAX UCITS ETF (ticker DBXD) is a Germany-focused equity fund that seeks to replicate the performance of the Morningstar Germany Total Market Index (TME) net-return, EUR-denominated. It is domiciled in Germany and trades on XETRA, offering investors a low-cost, passively managed exposure to the German blue-chip market.
Key additional metrics (as of Q3 2024) include an expense ratio of 0.09 % p.a., total assets under management of roughly €1.2 billion, and a 30-day tracking error of about 0.15 % points, indicating tight alignment with the underlying index. The DAX is heavily weighted toward industrials, automotive, and financial services, sectors that remain sensitive to Germany’s export-driven growth and the Eurozone’s monetary policy stance. Recent data show the DAX’s dividend yield hovering around 2.8 % and a forward-looking price-to-earnings multiple near 13×, both modestly below historical European averages, suggesting a potential valuation edge.
If you want a more granular, data-driven assessment of DBXD’s risk-adjusted performance and how it fits into broader portfolio construction, consider exploring the analytics available on ValueRay.
DBXD ETF Overview
| Market Cap in USD | 7,535m |
| Category | Germany Equity |
| TER | 0.09% |
| IPO / Inception | 2007-01-10 |
| Return 12m vs S&P 500 | 7.06% |
| Analyst Rating | - |
DBXD Dividends
Currently no dividends paidDBXD Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 16.52% |
| CAGR/Max DD Calmar Ratio | 1.04 |
| CAGR/Mean DD Pain Ratio | 7.33 |
| Current Volume | 67.8k |
| Average Volume | 51.3k |
What is the price of DBXD shares?
Over the past week, the price has changed by -3.15%, over one month by -5.02%, over three months by -4.87% and over the past year by +20.30%.
Is DBXD a buy, sell or hold?
What are the forecasts/targets for the DBXD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 247.3 | 14.1% |
DBXD Fundamental Data Overview November 18, 2025
Market Cap EUR = 6.50b (6.50b EUR * 1.0 EUR.EUR)
Beta = 0.96
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 6.50b EUR (6.50b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 6.50b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 6.50b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.68% (E(6.50b)/V(6.50b) * Re(6.68%) + (debt-free company))
Discount Rate = 6.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)